Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

about

Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200.Prognostic impact of CD200 and CD56 expression in pediatric B-cell acute lymphoblastic leukemia patients.

P2860

Q46971015-2BFC28BA-3C5A-4743-8E6B-0DD2FCDA5B58 Q49964009-3D9ADCF7-21A0-4C80-AFE4-1CD035740E1C

P2860

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Item

http://www.wikidata.org/entity/Q39532047

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@en

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@nl

type

Item

label

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@en

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@nl

prefLabel

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@en

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@nl

P1476

Tumor-derived vaccines contain ...... mplications for immunotherapy.

@en

P2093

Christopher L Moertel

http://www.w3.org/2001/XMLSchema#string

Craig M Horbinski

http://www.w3.org/2001/XMLSchema#string

Elisabet Ampudia-Mesias

http://www.w3.org/2001/XMLSchema#string

Michael R Olin

http://www.w3.org/2001/XMLSchema#string

Rob Shaver

http://www.w3.org/2001/XMLSchema#string

Zhengming Xiong

http://www.w3.org/2001/XMLSchema#string

P2860

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans

Chronic infection drives expression of the inhibitory receptor CD200R, and its ligand CD200, by mouse and human CD4 T cells

Structures of CD200/CD200 Receptor Family and Implications for Topology, Regulation, and Evolution

Dendritic cells and the control of immunity

Dissection of agonistic and blocking effects of CD200 receptor antibodies

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.

P304

1059-1071

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2016-0033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27485078

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

P932

5619161

http://www.w3.org/2001/XMLSchema#string

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

about

P2860

P2860

Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932